Erratum: (Arteriosclerosis, Thrombosis, and Vascular Biology (2015) 35 (918-929) DOI: 10.1161/ATVBAHA.114.305212);MicroRNA-22 regulates smooth muscle cell differentiation from stem cells by targeting methyl CpG-Binding protein 2

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 35, Issue 4, 2015, Pages 918-929

  Zhao, Hanqing ^a   Wen, Guanmei ^a   Huang, Yuan ^a,b   Yu, Xiaotian ^a   Chen, Qishan ^a,b   Afzal, Tayyab Adeel ^a   Luong, Le Anh ^a   Zhu, Jianhua ^a,b   Shu, Ye ^a   Zhang, Li ^a,b   Xiao, Qingzhong ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

cell differentiation; methyl CpG binding protein 2; microRNAs; myocytes, smooth muscle; stem cells

Indexed keywords

METHYL CPG BINDING PROTEIN 2; MICRORNA 22; PLATELET DERIVED GROWTH FACTOR BB; TRANSFORMING GROWTH FACTOR BETA; 3' UNTRANSLATED REGION; HISTONE; MECP2 PROTEIN, MOUSE; MICRORNA; MIRN22 MICRORNA, MOUSE; MYOCARDIN; NUCLEAR PROTEIN; OLIGONUCLEOTIDE; PHOSPHOLIPASE A2; PLA2G7 PROTEIN, MOUSE; PLATELET DERIVED GROWTH FACTOR B; PLATELET-DERIVED GROWTH FACTOR BB; SERUM RESPONSE FACTOR; TRANSACTIVATOR PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING SITE; CELL DIFFERENTIATION; CONTROLLED STUDY; DNA METHYLATION; EMBRYONIC STEM CELL; GENE OVEREXPRESSION; GENE SILENCING; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REGULATORY MECHANISM; SMOOTH MUSCLE FIBER; UPREGULATION; 3' UNTRANSLATED REGION; ANIMAL; CELL LINE; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; GENETICS; METABOLISM; METHYLATION; MUTATION; RNA INTERFERENCE; SERUM RESPONSIVE ELEMENT; SIGNAL TRANSDUCTION; TIME;

3' UNTRANSLATED REGIONS; ANIMALS; BINDING SITES; CELL DIFFERENTIATION; CELL LINE; EMBRYONIC STEM CELLS; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION; HISTONES; METHYL-CPG-BINDING PROTEIN 2; METHYLATION; MICE; MICRORNAS; MUTATION; MYOCYTES, SMOOTH MUSCLE; NUCLEAR PROTEINS; OLIGONUCLEOTIDES; PHOSPHOLIPASES A2; PROTO-ONCOGENE PROTEINS C-SIS; RNA INTERFERENCE; SERUM RESPONSE ELEMENT; SERUM RESPONSE FACTOR; SIGNAL TRANSDUCTION; TIME FACTORS; TRANS-ACTIVATORS; TRANSCRIPTION, GENETIC; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 84930246652     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATV.0000000000000020     Document Type: Erratum

References (54)

1. Huang Y, Lin L, Yu X, Wen G, Pu X, Zhao H, Fang C, Zhu J, Ye S, Zhang L, Xiao Q. Functional involvements of heterogeneous nuclear ribonucleoprotein A1 in smooth muscle differentiation from stem cells in vitro and in vivo. Stem Cells. 2013;31:906-917. doi: 10.1002/stem.1324.
2. Xiao Q, Pepe AE, Wang G, Luo Z, Zhang L, Zeng L, Zhang Z, Hu Y, Ye S, Xu Q. Nrf3-Pla2g7 interaction plays an essential role in smooth muscle differentiation from stem cells. Arterioscler Thromb Vasc Biol. 2012;32:730-744. doi: 10.1161/ATVBAHA.111.243188.
3. Xiao Q, Wang G, Yin X, Luo Z, Margariti A, Zeng L, Mayr M, Ye S, Xu Q. Chromobox protein homolog 3 is essential for stem cell differentiation to smooth muscles in vitro and in embryonic arteriogenesis. Arterioscler Thromb Vasc Biol. 2011;31:1842-1852. doi: 10.1161/ ATVBAHA.111.230110.
4. Wang G, Xiao Q, Luo Z, Ye S, Xu Q. Functional impact of heterogeneous nuclear ribonucleoprotein A2/B1 in smooth muscle differentiation from stem cells and embryonic arteriogenesis. J Biol Chem. 2012;287:2896-2906. doi: 10.1074/jbc.M111.297028.
5. Pepe AE, Xiao Q, Zampetaki A, Zhang Z, Kobayashi A, Hu Y, Xu Q. Crucial role of nrf3 in smooth muscle cell differentiation from stem cells. Circ Res. 2010;106:870-879. doi: 10.1161/CIRCRESAHA.109.211417.
6. Grieskamp T, Rudat C, Lüdtke TH, Norden J, Kispert A. Notch signaling regulates smooth muscle differentiation of epicardium-derived cells. Circ Res. 2011;108:813-823. doi: 10.1161/CIRCRESAHA.110.228809.
7. Singh N, Trivedi CM, Lu M, Mullican SE, Lazar MA, Epstein JA. Histone deacetylase 3 regulates smooth muscle differentiation in neural crest cells and development of the cardiac outflow tract. Circ Res. 2011;109:1240-1249. doi: 10.1161/CIRCRESAHA.111.255067.
8. Landgraf P, Rusu M, Sheridan R, et al. A mammalian microRNA expression atlas based on small RNA library sequencing. Cell. 2007;129:1401-1414. doi: 10.1016/j.cell.2007.04.040.
9. Oberdoerffer P, Kanellopoulou C, Heissmeyer V, Paeper C, Borowski C, Aifantis I, Rao A, Rajewsky K. Efficiency of RNA interference in the mouse hematopoietic system varies between cell types and developmental stages. Mol Cell Biol. 2005;25:3896-3905. doi: 10.1128/ MCB.25.10.3896-3905.2005.
10. Murchison EP, Partridge JF, Tam OH, Cheloufi S, Hannon GJ. Characterization of Dicer-deficient murine embryonic stem cells. Proc Natl Acad Sci U S A. 2005;102:12135-12140. doi: 10.1073/pnas.0505479102.
11. Wang Y, Medvid R, Melton C, Jaenisch R, Blelloch R. DGCR8 is essential for microRNA biogenesis and silencing of embryonic stem cell selfrenewal. Nat Genet. 2007;39:380-385. doi: 10.1038/ng1969.
12. Yang WJ, Yang DD, Na S, Sandusky GE, Zhang Q, Zhao G. Dicer is required for embryonic angiogenesis during mouse development. J Biol Chem. 2005;280:9330-9335. doi: 10.1074/jbc.M413394200.
13. Albinsson S, Suarez Y, Skoura A, Offermanns S, Miano JM, Sessa WC. MicroRNAs are necessary for vascular smooth muscle growth, differentiation, and function. Arterioscler Thromb Vasc Biol. 2010;30:1118-1126. doi: 10.1161/ATVBAHA.109.200873.
14. Pan Y, Balazs L, Tigyi G, Yue J. Conditional deletion of Dicer in vascular smooth muscle cells leads to the developmental delay and embryonic mortality. Biochem Biophys Res Commun. 2011;408:369-374. doi: 10.1016/j. bbrc.2011.02.119.
15. Ling B, Wang GX, Long G, Qiu JH, Hu ZL. Tumor suppressor miR-22 suppresses lung cancer cell progression through post-transcriptional regulation of ErbB3. J Cancer Res Clin Oncol. 2012;138:1355-1361. doi: 10.1007/s00432-012-1194-2.
16. Zhang G, Xia S, Tian H, Liu Z, Zhou T. Clinical significance of miR-22 expression in patients with colorectal cancer. Med Oncol. 2012;29:3108-3112. doi: 10.1007/s12032-012-0233-9.
17. Xu D, Takeshita F, Hino Y, Fukunaga S, Kudo Y, Tamaki A, Matsunaga J, Takahashi RU, Takata T, Shimamoto A, Ochiya T, Tahara H. miR-22 represses cancer progression by inducing cellular senescence. J Cell Biol. 2011;193:409-424. doi: 10.1083/jcb.201010100.
18. Jazbutyte V, Fiedler J, Kneitz S, Galuppo P, Just A, Holzmann A, Bauersachs J, Thum T. MicroRNA-22 increases senescence and activates cardiac fibroblasts in the aging heart. Age (Dordr). 2013;35:747-762. doi: 10.1007/s11357-012-9407-9.
19. Stadler B, Ivanovska I, Mehta K, Song S, Nelson A, Tan Y, Mathieu J, Darby C, Blau CA, Ware C, Peters G, Miller DG, Shen L, Cleary MA, Ruohola-Baker H. Characterization of microRNAs involved in embryonic stem cell states. Stem Cells Dev. 2010;19:935-950. doi: 10.1089/ scd.2009.0426.
20. Margariti A, Xiao Q, Zampetaki A, Zhang Z, Li H, Martin D, Hu Y, Zeng L, Xu Q. Splicing of HDAC7 modulates the srf-myocardin complex during stem-cell differentiation towards smooth muscle cells. J Cell Sci. 2009;122:460-470
21. Xiao Q, Luo Z, Pepe AE, Margariti A, Zeng L, Xu Q. Embryonic stem cell differentiation into smooth muscle cells is mediated by Nox4-produced H2O2. Am J Physiol Cell Physiol. 2009;296:C711-C723. doi: 10.1152/ ajpcell.00442.2008.
22. Xiao Q, Zeng L, Zhang Z, Hu Y, Xu Q. Stem cell-derived Sca-1+ progenitors differentiate into smooth muscle cells, which is mediated by collagen IV-integrin alpha1/beta1/alphav and PDGF receptor pathways. Am J Physiol Cell Physiol. 2007;292:C342-C352. doi: 10.1152/ ajpcell.00341.2006.
23. Zhang L, Jin M, Margariti A, Wang G, Luo Z, Zampetaki A, Zeng L, Ye S, Zhu J, Xiao Q. Sp1-dependent activation of HDAC7 is required for platelet-derived growth factor-BB-induced smooth muscle cell differentiation from stem cells. J Biol Chem. 2010;285:38463-38472. doi: 10.1074/jbc. M110.153999.
24. Yu X, Zhang L, Wen G, Zhao H, Luong LA, Chen Q, Huang Y, Zhu J, Ye S, Xu Q, Wang W, Xiao Q. Upregulated sirtuin 1 by miRNA-34a is required for smooth muscle cell differentiation from pluripotent stem cells. Cell Death Differ. 2014. doi: 10.1038/cdd.2014.206. [Epub ahead of print]
25. Hu Y, Zhang Z, Torsney E, Afzal AR, Davison F, Metzler B, Xu Q. Abundant progenitor cells in the adventitia contribute to atherosclerosis of vein grafts in ApoE-deficient mice. J Clin Invest. 2004;113:1258-1265. doi: 10.1172/JCI19628.
26. Xie C, Huang H, Sun X, Guo Y, Hamblin M, Ritchie RP, Garcia-Barrio MT, Zhang J, Chen YE. MicroRNA-1 regulates smooth muscle cell differentiation by repressing Kruppel-like factor 4. Stem Cells Dev. 2011;20:205-210. doi: 10.1089/scd.2010.0283.
27. Miano JM. Serum response factor: toggling between disparate programs of gene expression. J Mol Cell Cardiol. 2003;35:577-593.
28. Rosenfeld JA, Wang Z, Schones DE, Zhao K, DeSalle R, Zhang MQ. Determination of enriched histone modifications in non-genic portions of the human genome. BMC Genomics. 2009;10:143. doi: 10.1186/1471-2164-10-143.
29. Xie C, Ritchie RP, Huang H, Zhang J, Chen YE. Smooth muscle cell differentiation in vitro: models and underlying molecular mechanisms. Arterioscler Thromb Vasc Biol. 2011;31:1485-1494. doi: 10.1161/ ATVBAHA.110.221101.
30. Xiao Q, Wang G, Luo Z, Xu Q. The mechanism of stem cell differentiation into smooth muscle cells. Thromb Haemost. 2010;104:440-448. doi: 10.1160/TH09-11-0794.
31. Rodriguez A, Griffiths-Jones S, Ashurst JL, Bradley A. Identification of mammalian microrna host genes and transcription units. Genome Res. 2004;14:1902-1910
32. Cai X, Hagedorn CH, Cullen BR. Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs. RNA. 2004;10:1957-1966. doi: 10.1261/rna.7135204.
33. Xiong J, Du Q, Liang Z. Tumor-suppressive microRNA-22 inhibits the transcription of E-box-containing c-Myc target genes by silencing c-Myc binding protein. Oncogene. 2010;29:4980-4988. doi: 10.1038/ onc.2010.241.
34. Ting Y, Medina DJ, Strair RK, Schaar DG. Differentiation-associated miR-22 represses Max expression and inhibits cell cycle progression. Biochem Biophys Res Commun. 2010;394:606-611. doi: 10.1016/j. bbrc.2010.03.030.
35. Choong ML, Yang HH, McNiece I. MicroRNA expression profiling during human cord blood-derived CD34 cell erythropoiesis. Exp Hematol. 2007;35:551-564. doi: 10.1016/j.exphem.2006.12.002.
36. Filipowicz W, Bhattacharyya SN, Sonenberg N. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet. 2008;9:102-114. doi: 10.1038/nrg2290.
37. Patel JB, Appaiah HN, Burnett RM, Bhat-Nakshatri P, Wang G, Mehta R, Badve S, Thomson MJ, Hammond S, Steeg P, Liu Y, Nakshatri H. Control of EVI-1 oncogene expression in metastatic breast cancer cells through microRNA miR-22. Oncogene. 2011;30:1290-1301. doi: 10.1038/ onc.2010.510.
38. Zhang J, Yang Y, Yang T, Liu Y, Li A, Fu S, Wu M, Pan Z, Zhou W. microRNA-22, downregulated in hepatocellular carcinoma and correlated with prognosis, suppresses cell proliferation and tumourigenicity. Br J Cancer. 2010;103:1215-1220. doi: 10.1038/sj.bjc.6605895.
39. Bar N, Dikstein R. miR-22 forms a regulatory loop in PTEN/AKT pathway and modulates signaling kinetics. PLoS One. 2010;5:e10859. doi: 10.1371/journal.pone.0010859.
40. Pandey DP, Picard D. miR-22 inhibits estrogen signaling by directly targeting the estrogen receptor alpha mRNA. Mol Cell Biol. 2009;29:3783-3790. doi: 10.1128/MCB.01875-08.
41. Song SJ, Ito K, Ala U, Kats L, Webster K, Sun SM, Jongen-Lavrencic M, Manova-Todorova K, Teruya-Feldstein J, Avigan DE, Delwel R, Pandolfi PP. The oncogenic microRNA miR-22 targets the TET2 tumor suppressor to promote hematopoietic stem cell self-renewal and transformation. Cell Stem Cell. 2013;13:87-101. doi: 10.1016/j. stem.2013.06.003.
42. Bogdanović O, Veenstra GJ. DNA methylation and methyl-CpG binding proteins: developmental requirements and function. Chromosoma. 2009;118:549-565. doi: 10.1007/s00412-009-0221-9.
43. Chen RZ, Akbarian S, Tudor M, Jaenisch R. Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice. Nat Genet. 2001;27:327-331. doi: 10.1038/85906.
44. Guy J, Hendrich B, Holmes M, Martin JE, Bird A. A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome. Nat Genet. 2001;27:322-326. doi: 10.1038/85899.
45. Chan GC, Fish JE, Mawji IA, Leung DD, Rachlis AC, Marsden PA. Epigenetic basis for the transcriptional hyporesponsiveness of the human inducible nitric oxide synthase gene in vascular endothelial cells. J Immunol. 2005;175:3846-3861.
46. Hu B, Gharaee-Kermani M, Wu Z, Phan SH. Essential role of MeCP2 in the regulation of myofibroblast differentiation during pulmonary fibrosis. Am J Pathol. 2011;178:1500-1508. doi: 10.1016/j.ajpath.2011.01.002.
47. Agarwal N, Hardt T, Brero A, Nowak D, Rothbauer U, Becker A, Leonhardt H, Cardoso MC. MeCP2 interacts with HP1 and modulates its heterochromatin association during myogenic differentiation. Nucleic Acids Res. 2007;35:5402-5408. doi: 10.1093/nar/gkm599.
48. Okabe Y, Kusaga A, Takahashi T, Mitsumasu C, Murai Y, Tanaka E, Higashi H, Matsuishi T, Kosai K. Neural development of methyl-CpG-binding protein 2 null embryonic stem cells: A system for studying Rett syndrome. Brain Res. 2010;1360:17-27. doi: 10.1016/j.brainres.2010.08.090.
49. Tsujimura K, Abematsu M, Kohyama J, Namihira M, Nakashima K. Neuronal differentiation of neural precursor cells is promoted by the methyl-CpG-binding protein MeCP2. Exp Neurol. 2009;219:104-111. doi: 10.1016/j.expneurol.2009.05.001.
50. Szulwach KE, Li X, Smrt RD, Li Y, Luo Y, Lin L, Santistevan NJ, Li W, Zhao X, Jin P. Cross talk between microRNA and epigenetic regulation in adult neurogenesis. J Cell Biol. 2010;189:127-141. doi: 10.1083/ jcb.200908151.
51. Zhang X, Cui N, Wu Z, Su J, Tadepalli JS, Sekizar S, Jiang C. Intrinsic membrane properties of locus coeruleus neurons in Mecp2-null mice. Am J Physiol Cell Physiol. 2010;298:C635-C646. doi: 10.1152/ ajpcell.00442.2009.
52. Tate P, Skarnes W, Bird A. The methyl-CpG binding protein MeCP2 is essential for embryonic development in the mouse. Nat Genet. 1996;12:205-208. doi: 10.1038/ng0296-205.
53. Mellén M, Ayata P, Dewell S, Kriaucionis S, Heintz N. MeCP2 binds to 5hmC enriched within active genes and accessible chromatin in the nervous system. Cell. 2012;151:1417-1430. doi: 10.1016/j.cell.2012.11.022.
54. Fuks F, Hurd PJ, Wolf D, Nan X, Bird AP, Kouzarides T. The methyl-CpGbinding protein MeCP2 links DNA methylation to histone methylation. J Biol Chem. 2003;278:4035-4040. doi: 10.1074/jbc.M210256200.